In this prior work, the effects in prostate and colon cancer cells were consistent with the role of FRAT1 in preventing the association of GSK-3β with the destruction complex, while the downregulation of PAK4 inhibited nuclear translocation of β-catenin (13). The gene discussed is PAK4; the disease is malignant colon neoplasm.